Novo Nordisk's marketing partnership with diabetic race car driver Charlie Kimball is one of the most provocative examples of how pharmaceutical companies are cleverly navigating the emerging, largely unregulated social-media space. Report
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Comments